Prilosec OTC “Coverage Gap” Pitch Spotlights Medicare Payment Question

An initiative promoting Prilosec OTC over prescription competitors to help Medicare Part D users avoid "the coverage gap" in their prescription costs may prompt a closer look at ways Medicare can pay for OTCs

More from Archive

More from Pink Sheet